LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 82.01 | 27.76 | 5446 | 7000 | 0.7780 | 0.9380 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 82.01 | 27.76 | 10604 | 7000 | 1.5148 | 1.1069 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 83.72 | 27.76 | 292 | 7055 | 0.0414 | 0.3425 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 83.72 | 27.76 | 7254 | 7055 | 1.0281 | 1.0070 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 83.72 | 27.76 | 5030 | 7055 | 0.7129 | 0.9171 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 83.72 | 27.76 | 10922 | 7055 | 1.5480 | 1.1124 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 85.42 | 27.76 | 170 | 7025 | 0.0242 | 0.2548 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 85.42 | 27.76 | 7182 | 7025 | 1.0223 | 1.0055 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 85.42 | 27.76 | 4493 | 7025 | 0.6395 | 0.8911 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 85.42 | 27.76 | 11155 | 7025 | 1.5878 | 1.1192 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.13 | 27.76 | 33 | 6987 | 0.0047 | 0.0219 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.13 | 27.76 | 7097 | 6987 | 1.0156 | 1.0039 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.13 | 27.76 | 4929 | 6987 | 0.7054 | 0.9144 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.13 | 27.76 | 11379 | 6987 | 1.6284 | 1.1261 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 88.84 | 27.76 | 16 | 6965 | 0.0023 | -0.0668 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 88.84 | 27.76 | 6863 | 6965 | 0.9854 | 0.9963 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 88.84 | 27.76 | 4846 | 6965 | 0.6958 | 0.9110 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 88.84 | 27.76 | 11666 | 6965 | 1.6749 | 1.1337 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 90.55 | 27.76 | 5 | 6928 | 0.0007 | -0.1937 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 90.55 | 27.76 | 6557 | 6928 | 0.9464 | 0.9862 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 90.55 | 27.76 | 4131 | 6928 | 0.5962 | 0.8743 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 90.55 | 27.76 | 11810 | 6928 | 1.7045 | 1.1385 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.25 | 27.76 | 2 | 6873 | 0.0003 | -0.2816 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.25 | 27.76 | 5684 | 6873 | 0.8270 | 0.9528 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.25 | 27.76 | 3765 | 6873 | 0.5478 | 0.8542 | MN20160318_Q01 | F13 |